Attività
Vendite per attività
GBP in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Artificial Intelligence-enabled in Vitro Diagnostics
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +26,61% |
Vendite per regione
GBP in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +26,61% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 15/03/18 |
Howard Doran
PSD | President | 63 | 01/09/23 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 15/03/18 |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 70 | 15/03/18 |
Joseph Hutson
PRN | Corporate Officer/Principal | - | 22/07/21 |
Sales & Marketing | - | 07/06/21 | |
Salim Hamir
SEC | Corporate Secretary | - | - |
Jed Fulk
SAM | Sales & Marketing | 64 | 07/10/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 30/08/21 |
Chairman | 72 | 15/03/18 | |
James McCullough
FOU | Founder | 56 | 15/03/18 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 15/03/18 |
Erik Lium
BRD | Director/Board Member | 56 | 01/11/18 |
Catherine Coste
BRD | Director/Board Member | 58 | 30/06/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 154 368 191 | 94 984 051 ( 61,53 %) | 0 | 61,53 % |
Coordinate società
![Indirizzo Renalytix Ai PLC](https://cdn.zonebourse.com/static/address/47041179.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
-26,59% | 16,26 Mrd | |
-50,54% | 2,44 Mrd | |
+25,26% | 1,98 Mrd | |
-8,81% | 1,52 Mrd | |
+26,93% | 1,3 Mrd | |
-18,54% | 937 Mln | |
-32,14% | 775 Mln | |
-0,29% | 760 Mln | |
-26,54% | 615 Mln |